- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/12 - Cyclic peptides
Patent holdings for IPC class A61K 38/12
Total number of patents in this class: 2944
10-year publication summary
249
|
259
|
212
|
269
|
245
|
283
|
260
|
206
|
181
|
63
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The Regents of the University of California | 19681 |
46 |
Aileron Therapeutics, Inc. | 80 |
37 |
Bristol-myers Squibb Company | 4848 |
34 |
Shanghai Techwell Biopharmaceutical Co., Ltd. | 66 |
28 |
Novartis AG | 11042 |
27 |
Apellis Pharmaceuticals, Inc. | 120 |
27 |
Chugai Seiyaku Kabushiki Kaisha | 1319 |
25 |
Polyphor AG | 89 |
24 |
Palatin Technologies, Inc. | 74 |
23 |
Ra Pharmaceuticals, Inc. | 69 |
22 |
Ohio State Innovation Foundation | 2048 |
21 |
Bicyclerd Limited | 142 |
21 |
University of South Florida | 1811 |
20 |
Centre National de La Recherche Scientifique | 10202 |
18 |
Rhythm Pharmaceuticals, Inc. | 66 |
18 |
Helperby Therapeutics Limited | 63 |
17 |
Saint Regis Mohawk Tribe | 23 |
17 |
President and Fellows of Harvard College | 5905 |
16 |
Peptidream Inc. | 74 |
16 |
Bicycletx Limited | 173 |
16 |
Other owners | 2471 |